Pharmacogenomics
Another new treatment for depression is pharmacogenomics. It is a combination of psychopharmacology and genetics. The basic principle is to find out the medication that can works best for the specific form of depression in the patient. As a result, it would help save time on the trial and error approaches, which often test various drugs for weeks. In many cases, this can significantly improve the patients’ quality of life because the early implementation can help prevent some serious complications. It is especially true for those who have suicidal thoughts and experience despair. [2]
